Former CDM chief Kyle Barich jumps from healthcare to cannabis
Barich stepped down as CEO of CDM in June.
News
Five things for pharma marketers to know: Wednesday, October 23, 2019
Biogen resurrects Alzheimer’s drug in light of new analysis; ACA premiums expected to drop next year; Novartis gene therapy Zolgensma beats sales expectations.
FDA’s first ‘modified risk’ tobacco products set precedent
They could set the standard for vaping products.
Timeline: Pharma navigates the first federal opioid trial
The case brought by two Ohio counties was set to be a bellwether for the remaining federal lawsuits.
Interpublic Q3 revenue edge up 1.4%
Media, healthcare marketing, PR and sports and entertainment offerings led growth.
Five things for pharma marketers to know: Tuesday, October 22, 2019
Drug companies reach last-minute settlement in Ohio; Larger opioid settlement talks could resume with trial delayed; Trump urges HHS to speed drug-importation plans.
Elevate’s Tara Powers on in-your-face creative, shark cage diving and her open door policy
Tara Powers is the creative director of Philadelphia-based Elevate Healthcare.
Last-minute settlements delay Ohio opioid trial
Three drug distributors and a pharma company reached deals to avoid going to trial Monday.
Five things for pharma marketers to know: Monday, October 21, 2019
FDA finds asbestos in J&J baby powder; Pelosi’s drug price bill passes first House committee; Sanofi recalls heartburn medicine Zantac over traces of carcinogen.
POC trade group publishes verification and validation guidance
The point-of-care industry had been looking to formalize a rules framework since allegations of fraud leveled against Outcome Health revealed a need for better auditing.
Want to read more?
Please login or register first to view this content.
